🔎 Trials Near Me

Home › COPD › Kansas › Kansas City

COPD clinical trials in Kansas City, KS

9 studies for COPD are looking for participants at sites in and around Kansas City (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment

RecruitingPhase 2
  • University of Kansas Medical Center Research Institute, Inc., Kansas City
Ages 40 to 85 · All sexes · Updated Oct 28, 2026 · NCT07684820

A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease

RecruitingPhase 2/3
  • University of Kansas Medical Center, Kansas City
Ages 35 to 80 · All sexes · Updated Oct 22, 2026 · NCT07363694

A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.

RecruitingPhase 4
  • University of Kansas Medical Center- Site Number : 8400005, Kansas City
Ages 40 to 85 · All sexes · Updated Oct 20, 2026 · NCT07053423

Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3

Recruiting
  • University of Kansas Medical Center Research Institute, Kansas City
Ages 40 to 84 · All sexes · Updated Oct 19, 2026 · NCT06891755

Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype

RecruitingPhase 3
  • University of Kansas Medical Center- Site Number : 8400054, Kansas City
Ages 40 to 80 · All sexes · Updated Oct 19, 2026 · NCT07190209

A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)

RecruitingPhase 3
  • Research Site, Kansas City
Ages 40 to 80 · All sexes · Updated Oct 9, 2026 · NCT06878261

Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD

RecruitingPhase 2
  • University of Kansas Medical Center, Kansas City
Ages 40 and older · All sexes · Updated Sep 4, 2026 · NCT07059091

Evaluation of Ventilation Defects Downstream of Mucus Plugs in Patients With Muco-Obstructive Lung Disease

RecruitingObservational study
  • University of Kansas Medical Center, Kansas City
Ages 18 to 65 · All sexes · Updated Jul 1, 2026 · NCT06985225

Hyperpolarized 129Xe MR Imaging of Lung Function in Healthy Volunteers and Subjects With Pulmonary Disease

RecruitingPhase 1Healthy volunteers welcome
  • University of Kansas Medical Center, Kansas City
Ages 3 and older · All sexes · Updated May 6, 2026 · NCT04624490

About COPD

COPD (chronic obstructive pulmonary disease) makes it hard for you to breathe. At first symptoms are mild, but they usually become more severe. Learn more.

More about COPD on MedlinePlus

COPD trials in other cities

Other studies in Kansas City

From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.